Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection (Q43651001)
Jump to navigation
Jump to search
scientific article published in March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection |
scientific article published in March 2011 |
Statements
1 reference
Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection (English)
1 reference
Calvin Cohen
1 reference
Richard Elion
1 reference
Peter Ruane
1 reference
David Shamblaw
1 reference
Edwin DeJesus
1 reference
Bruce Rashbaum
1 reference
Steven L Chuck
1 reference
Kitty Yale
1 reference
Hui C Liu
1 reference
David R Warren
1 reference
Srinivasan Ramanathan
1 reference
Brian P Kearney
1 reference
1 March 2011
1 reference
Identifiers
1 reference